211 related articles for article (PubMed ID: 11182343)
1. Sclerotherapy for venous malformations of the glans penis.
Marrocco-Trischitta MM; Nicodemi EM; Stillo F
Urology; 2001 Feb; 57(2):310-3. PubMed ID: 11182343
[TBL] [Abstract][Full Text] [Related]
2. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations.
Jain R; Bandhu S; Sawhney S; Mittal R
J Clin Ultrasound; 2002 Sep; 30(7):416-23. PubMed ID: 12210459
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous sclerotherapy of peripheral venous malformations in pediatric patients.
Gulsen F; Cantasdemir M; Solak S; Gulsen G; Ozluk E; Numan F
Pediatr Surg Int; 2011 Dec; 27(12):1283-7. PubMed ID: 21818522
[TBL] [Abstract][Full Text] [Related]
4. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
Rabe E; Schliephake D; Otto J; Breu FX; Pannier F
Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861
[TBL] [Abstract][Full Text] [Related]
5. Treatment of venous malformations with sclerosant in microfoam form.
Cabrera J; Cabrera J; Garcia-Olmedo MA; Redondo P
Arch Dermatol; 2003 Nov; 139(11):1409-16. PubMed ID: 14623700
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
Bush R; Bush P
Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
[TBL] [Abstract][Full Text] [Related]
7. Sclerotherapy of craniofacial venous malformations: complications and results.
Berenguer B; Burrows PE; Zurakowski D; Mulliken JB
Plast Reconstr Surg; 1999 Jul; 104(1):1-11; discussion 12-5. PubMed ID: 10597669
[TBL] [Abstract][Full Text] [Related]
8. Color duplex-guided sclerotherapy for the treatment of venous malformations.
Yamaki T; Nozaki M; Sasaki K
Dermatol Surg; 2000 Apr; 26(4):323-8. PubMed ID: 10759818
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous sclerotherapy for venous malformations using polidocanol under fluoroscopy.
Mimura H; Kanazawa S; Yasui K; Fujiwara H; Hyodo T; Mukai T; Dendo S; Iguchi T; Hiraki T; Koshima I; Hiraki Y
Acta Med Okayama; 2003 Oct; 57(5):227-34. PubMed ID: 14679400
[TBL] [Abstract][Full Text] [Related]
10. Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations.
Khandpur S; Sharma VK
Dermatol Surg; 2010 Mar; 36(3):340-6. PubMed ID: 20100267
[TBL] [Abstract][Full Text] [Related]
11. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures.
Barranco-Pons R; Burrows PE; Landrigan-Ossar M; Trenor CC; Alomari AI
AJR Am J Roentgenol; 2012 Sep; 199(3):691-4. PubMed ID: 22915413
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
Markovic JN; Nag U; Shortell CK
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312
[TBL] [Abstract][Full Text] [Related]
13. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation.
Marrocco-Trischitta MM; Guerrini P; Abeni D; Stillo F
Dermatol Surg; 2002 Feb; 28(2):153-5. PubMed ID: 11860427
[TBL] [Abstract][Full Text] [Related]
14. Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief.
Mimura H; Fujiwara H; Hiraki T; Gobara H; Mukai T; Hyodo T; Iguchi T; Yasui K; Kimata Y; Kanazawa S
Eur Radiol; 2009 Oct; 19(10):2474-80. PubMed ID: 19440712
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations.
Yamaki T; Sasaki Y; Hasegawa Y; Osada A; Konoeda H; Hamahata A; Nozaki M; Sakurai H
J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):707-714. PubMed ID: 28818226
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.
Tan KT; Kirby J; Rajan DK; Hayeems E; Beecroft JR; Simons ME
J Vasc Interv Radiol; 2007 Mar; 18(3):343-51. PubMed ID: 17377179
[TBL] [Abstract][Full Text] [Related]
17. [Injection sclerotherapy for varicosities of the lower limb: 25 years of experience with 115000 injections].
Bihari I
Orv Hetil; 2007 Jan; 148(2):51-8. PubMed ID: 17344119
[TBL] [Abstract][Full Text] [Related]
18. Complications of sclerotherapy for 75 head and neck venous malformations.
Castrén E; Aronniemi J; Klockars T; Pekkola J; Lappalainen K; Vuola P; Salminen P; Pitkäranta A
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1027-36. PubMed ID: 25731642
[TBL] [Abstract][Full Text] [Related]
19. Safety and effectiveness of percutaneous sclerotherapy for venous disorders of the labia majora in patients with vascular malformations.
Brill R; Deistung A; Gussew A; Goldann C; Stangl F; Uller W; Rosendahl J; Wildgruber M; Wohlgemuth WA
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1083-1089. PubMed ID: 32199800
[TBL] [Abstract][Full Text] [Related]
20. Sodium tetradecyl sulphate direct intralesional sclerotherapy of venous malformations of the vulva and vagina: report of five cases.
Krokidis M; Venetucci P; Hatzidakis A; Iaccarino V
Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S228-31. PubMed ID: 20559638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
